Tuesday, July 7, 2026

How to List Authors and Addresses in a Scientific Paper: The Tiny Byline That Carries a Whole Republic

The author line of a scientific paper looks deceptively simple:

A. Sharma¹, R. Gupta², M. Singh¹,³*

A few names. A few superscript numbers. A star. Perhaps an email address.

But this small strip of text is one of the most politically charged, ethically important, career-shaping regions of the entire paper. It decides who gets credit, who carries responsibility, which institutions are recognized, who speaks for the work, and how the paper will be found, counted, indexed, cited, evaluated, and argued over for years.

The byline is not decoration. It is the paper’s passport control desk. 🛂📄


1. What does authorship actually mean?

Authorship is both credit and accountability. The International Committee of Medical Journal Editors, or ICMJE, states that authorship has academic, social, and financial implications, but also implies responsibility and accountability for the published work. (ICMJE)

This double nature is essential. Authorship is not a thank-you note. It is not a reward for being senior. It is not a political garland. It says:

“I made a qualifying intellectual contribution, I approved this paper, and I am willing to take responsibility for its integrity.”

The ICMJE recommends four criteria for authorship: substantial contribution to conception/design or data acquisition/analysis/interpretation, drafting or critically revising the work, final approval of the published version, and agreement to be accountable for all aspects of the work. All four criteria should be met. (ICMJE)

A useful rule:

If someone deserves credit but cannot take responsibility, they may belong in the acknowledgements.
If someone takes responsibility but did not contribute intellectually, they do not belong as an author.

That sounds simple. In real labs, it can become a monsoon in a teacup.


2. Who should be an author?

A person should usually be considered for authorship when they have made a substantial intellectual contribution to the work. This may include designing the study, developing the hypothesis, generating key data, analyzing results, interpreting findings, writing the manuscript, or critically revising it.

Examples of contributions that often support authorship:

ContributionUsually supports authorship?
Designed the studyYes
Developed the central hypothesisYes
Generated major experimental or clinical dataOften yes
Performed substantial analysis or modelingOften yes
Interpreted results intellectuallyYes
Wrote the first draftYes
Critically revised the manuscript for intellectual contentYes
Approved the final version and accepts accountabilityRequired

But some activities alone do not normally qualify for authorship. ICMJE specifically notes that acquisition of funding, general supervision, administrative support, technical editing, language editing, proofreading, and writing assistance alone do not qualify someone for authorship, although such contributors may be acknowledged. (ICMJE)

This distinction is crucial. A department head who only provided permission is not automatically an author. A technician who performed routine work may be acknowledged unless their contribution became intellectually substantial. A statistician who designed the analysis and interpreted results may very much deserve authorship. A “senior name” added to improve prestige is not authorship. It is academic incense smoke.


3. Ghost, guest, gift, and honorary authorship

Authorship problems have wonderfully theatrical names, but they are not harmless.

ProblemMeaning
Ghost authorshipSomeone who made a substantial contribution is omitted
Guest authorshipSomeone is added because their name may increase prestige or publication chances
Gift or honorary authorshipSomeone is added due to hierarchy, friendship, gratitude, or position rather than contribution

The Council of Science Editors defines guest authorship as authorship based on the expectation that including a name will improve publication chances or status, even when the person made no discernible contribution. It defines honorary or gift authorship as authorship based on tenuous affiliation, such as department-head status alone. (councilscienceeditors.org)

Ghost authorship is the opposite sin: someone who actually contributed meaningfully is hidden. This is especially dangerous in industry-sponsored or medical writing contexts, where hiding a writer, analyst, sponsor, or designer can obscure responsibility and conflicts of interest.

A paper with gift authors becomes inflated. A paper with ghost authors becomes haunted. 👻


4. Who decides the author list?

The authors do. Not the journal editor.

ICMJE says the people who conduct the work are responsible for identifying who meets authorship criteria, ideally while planning the work and then revisiting the decision as the project evolves. It also states that the author group, not editors, decides author order, and that unresolved authorship disputes should be investigated by the institution where the work was performed. (ICMJE)

This is why authorship should be discussed early, not after the manuscript is ready. A good project begins with an authorship conversation and keeps a living authorship record.

A practical authorship workflow:

  1. Discuss expected authorship at project start.

  2. Record expected roles.

  3. Revisit after major experiments, analysis, and drafting.

  4. Confirm order before submission.

  5. Get approval from every author before submission.

  6. Keep documentation of contributions.

Authorship delayed is resentment fermented.


5. Author order: why the first and last positions sparkle

In many biomedical, life-science, and experimental fields, author order is contribution-sensitive.

Common convention:

PositionUsual meaning in many biomedical/life-science fields
First authorDid most of the work and often wrote the first draft
Middle authorsContributed in decreasing, negotiated, or role-based order
Last authorSenior supervising author, principal investigator, or group leader
Corresponding authorHandles journal communication and post-publication queries

This is not universal law. It is convention. But careers are built on conventions, which means bylines must be handled carefully.

The first author often receives major credit for execution. The last author often receives credit for supervision, conceptual leadership, funding, laboratory direction, or senior responsibility. In many biomedical contexts, a strong publication record is read not only by counting papers, but by reading positions: first-author papers, corresponding-author papers, and senior-author papers.

But conventions vary. A physicist, economist, mathematician, clinician, historian, and computational biologist may read the same byline differently. The author list is a dialect, and every field has an accent.


6. Alphabetical authorship: when order is not contribution

Some fields list authors alphabetically. Mathematics is one of the classic examples. A 2025 study in Scientometrics describes mathematics as one of the few scientific disciplines where alphabetical ordering of co-authors remains the prevailing convention rather than contribution-based ordering. (Springer)

Economics also commonly uses alphabetical ordering. The American Economic Association notes that economics papers typically list coauthors alphabetically, and only a minority of two-author pairs reverse the order to signal greater contribution by the first author. (American Economic Association)

A broader bibliometric study found that intentional alphabetical authorship was declining overall, with mathematics, economics, and high-energy physics among the fields where it remained most common. (ScienceDirect)

Alphabetical authorship has virtues: it avoids endless contribution-ranking battles and can signal equality. But it also has problems. Alphabetical order can hide unequal contribution and may advantage researchers whose surnames appear earlier in the alphabet. The AEA specifically notes concerns that earlier names receive more visibility and that the “et al.” convention can obscure later names. (American Economic Association)

So the best practice is simple:

If author order is alphabetical, say so clearly.

Example footnote:

“Authors are listed alphabetically; all authors contributed equally to the conceptual development of the work.”

Or:

“Authors are listed alphabetically according to field convention. Individual contributions are specified in the Author Contributions section.”


7. Shared first authorship and equal contribution

Modern papers increasingly include shared authorship notes:

“These authors contributed equally: A. Sharma and R. Gupta.”

This is common when two researchers contributed comparably to experimental work, analysis, or manuscript preparation. Shared first authorship is useful, but it should not be sprinkled like decorative confetti. It should reflect genuine comparable contribution.

Important points:

  • Journals differ in how many equal first authors they allow.

  • Some indexing systems do not fully capture equal contribution.

  • CVs should explicitly mark equal contribution.

  • The first listed among equal contributors may still receive more visibility in citations.

  • Equal contribution should be reflected in the Author Contributions section.

Nature Portfolio allows one set of co-authors to be marked as having contributed equally and one set to be marked as jointly supervising the work; other equal contributions are best described in author contribution statements. (Nature)

Example:

“A.S. and R.G. contributed equally to experimental design, data generation, analysis, and manuscript drafting.”

That is better than a bare symbol with no explanation.


8. Shared senior authorship and joint supervision

Some papers state:

“M.S. and N.R. jointly supervised this work.”

This is especially common in collaborative biomedical, engineering, computational, and multi-lab papers. It signals that two or more senior investigators provided major intellectual, supervisory, infrastructural, or funding leadership.

But joint supervision should be used carefully. It should not be a consolation prize for authorship politics. It should answer: who actually supervised the work, took senior responsibility, shaped interpretation, secured resources, and helped steer the manuscript?

A clean statement:

“M.S. and N.R. jointly supervised the project, secured funding, interpreted the data, and critically revised the manuscript.”

Again, the contribution statement is the broom that sweeps away ambiguity.


9. The corresponding author: the paper’s diplomatic passport

The corresponding author is not automatically the most important scientist, although they often are. Their main role is communication and coordination.

ICMJE defines the corresponding author as the person who takes primary responsibility for communication with the journal during submission, peer review, and publication. This person typically ensures that administrative requirements such as authorship details, ethics approval, trial registration, and disclosures are completed. (ICMJE)

Nature Portfolio describes the corresponding author as responsible for ensuring all authors agree to be listed, approve submission, and for managing communication between the journal and co-authors before and after publication. It also assigns the corresponding author responsibilities for competing interest statements, data/code/materials transparency, proof accuracy, and post-publication queries. (Nature)

The corresponding author must therefore be organized, responsive, and trusted. They are the switchboard operator in the storm.

Responsibilities usually include:

  • submitting the manuscript,

  • communicating with the editor,

  • coordinating responses to reviewers,

  • confirming author approval,

  • checking proofs,

  • ensuring affiliation/address accuracy,

  • handling data/code/material requests,

  • answering post-publication questions,

  • informing co-authors about corrections or concerns.

Some papers have multiple corresponding authors, especially in multi-lab collaborations. But one person often remains the submission-system contact.


10. Can the first author also be the corresponding author?

Yes. In many cases, the first author may also be corresponding author, especially when they led the work and can handle technical questions. In some fields, however, the senior author is commonly corresponding author because they control the lab, grant, samples, long-term data storage, and post-publication responsibility.

A sensible rule:

The corresponding author should be the person best able to handle editorial communication and future questions about the work.

For a PhD student-led paper, a student can be corresponding author if the journal allows it and the team agrees. But long-term availability matters. If the student is moving institutions, a senior co-corresponding author may help preserve continuity.


11. Author contribution statements: the byline’s X-ray

A byline tells us who. A contribution statement tells us how.

Many journals now require author contribution statements because author order alone cannot express complex teamwork. ICMJE notes that some journals request and publish information about contributions, and editors are encouraged to implement contributorship policies. (ICMJE)

The CRediT taxonomy is one widely adopted system. It is a community-owned taxonomy of 14 contributor roles designed to capture key types of contributions to research outputs, including journal articles. Its roles include conceptualization, data curation, formal analysis, funding acquisition, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing-original draft, and writing-review and editing. (CRediT)

A strong contribution statement looks like this:

Conceptualization: R.D., N.A.
Methodology: M.A., R.D., N.A.
Investigation: M.A., S.K.
Formal analysis: M.A., P.R.
Visualization: M.A.
Supervision: N.A., R.D.
Funding acquisition: N.A.
Writing, original draft: M.A.
Writing, review and editing: all authors.

This is much better than:

“All authors contributed equally.”

That phrase is sometimes true. Often it is fog wearing a badge.


12. Acknowledgements: credit without authorship

Not everyone who helps should be an author. But many people deserve visible thanks.

Acknowledgements may include:

  • technical assistance,

  • language editing,

  • administrative help,

  • equipment access,

  • sample collection support,

  • general supervision not meeting authorship threshold,

  • funding or institutional support,

  • advice from colleagues,

  • permission to use facilities,

  • medical writing assistance, when appropriate and transparent.

ICMJE says contributors who meet fewer than all authorship criteria should not be listed as authors but should be acknowledged. (ICMJE)

Important courtesy: some journals require permission from acknowledged individuals because acknowledgement may imply endorsement.

A good acknowledgement is precise:

“We thank Dr. X for assistance with SEM imaging and Ms. Y for technical support during hydrogel preparation.”

Not:

“We thank everyone who helped directly or indirectly.”

That line is sweet but nutritionally thin.


13. AI authorship: can ChatGPT be an author?

No, under major current biomedical and publication-ethics guidance, AI tools should not be listed as authors.

ICMJE states that humans are responsible for submitted material that includes AI-assisted technologies, that authors should review and edit AI output because it may be incorrect, incomplete, or biased, and that authors should not list AI or AI-assisted technologies as authors or co-authors. (ICMJE)

ICMJE also states that authors must ensure appropriate attribution for quoted material and that referencing AI-generated material as a primary source is not acceptable. (ICMJE)

COPE similarly states that authors are fully responsible for manuscript content, including AI-produced parts, and that AI tools cannot take responsibility in the way human authors can. (Publication Ethics)

Why AI cannot be an author:

Authorship requirementCan AI satisfy it?
Take legal and ethical responsibilityNo
Approve final version as accountable agentNo
Resolve integrity questionsNo
Hold conflicts of interestNo
Be contacted after publicationNo
Understand institutional obligationsNo

But AI use may need to be disclosed depending on journal policy. A good disclosure might say:

“The authors used an AI-assisted language tool to improve grammar and clarity. All scientific content, interpretation, citations, and final wording were reviewed and approved by the human authors, who take full responsibility for the manuscript.”

Do not hide AI use if the journal asks for disclosure. Also, never cite AI as though it were a primary source. It is a tool, not a witness.


14. Author affiliations and addresses: why they matter

Affiliations and addresses are not clerical leftovers. They affect:

  • institutional credit,

  • funding assessment,

  • indexing,

  • discoverability,

  • conflict-of-interest assessment,

  • correspondence,

  • institutional reporting,

  • collaborations,

  • accountability,

  • geographic context,

  • research equity.

Nature Portfolio states that the primary affiliation for each author should be the institution where the majority of the work was done, and a current address may be stated if the author has moved. (Nature) Taylor & Francis similarly says authors should list relevant affiliations to attribute where the research was approved, supported, or conducted, and if authors have moved, they should list the affiliation where the work was conducted and include the current affiliation as a note. (Author Services)

A good affiliation usually includes:

Department, Institution, City, State/Province if needed, Postal code if required, Country.

Example:

¹ Department of Science, All India Sciences Bhopal, Bhopal, Madhya Pradesh, India
² Department of Science, All India Sciences Bhopal, Bhopal, Madhya Pradesh, India
³ Present address: Department of Biomedical Engineering, X University, City, Country
* Correspondence: author@email.edu

Avoid:

¹ AIS
² Lab
³ India

That is not an address. That is a breadcrumb.


15. Multiple affiliations: how to list them clearly

Many authors belong to more than one institution. Use superscript numbers to map authors to affiliations.

Example:

Siya Agrawal¹, Amit Shah², Nita Singh¹*

¹ Department of Science, AIS Bhopal, Bhopal, India
² Department of Science, AIS Bhopal, Bhopal, India
* Correspondence: author@example.edu

For multiple affiliations:

Ajit R. Dwivedi¹,²

Then list both institutions.

Best practices:

  • Use each affiliation once.

  • Use consistent institutional names.

  • Avoid abbreviations unless globally recognizable or defined.

  • Include present address separately.

  • Do not list honorary affiliations unless relevant and permitted.

  • Ensure all authors approve their affiliations.

  • Confirm spellings before proof approval.

Nature Portfolio says the corresponding author is responsible after acceptance for accuracy of names, addresses, and affiliations in the proof. (Nature)

That means one wrong department name can become a permanent metadata tattoo.


16. Names, initials, ORCID, and identity

Author names are not always simple. Initials can collapse different people into one shadow. Names may change. Transliteration may vary. Some people have mononyms. Some names include particles, accents, hyphens, multiple family names, or non-Roman scripts.

ORCID helps reduce this confusion. ORCID describes itself as a free, unique, persistent identifier for individuals involved in research, scholarship, and innovation. (ORCID) Nature Portfolio requires corresponding authors of published papers to provide an ORCID iD and encourages co-authors to provide one. (Nature)

Best practices:

  • Use the same name format across publications where possible.

  • Use ORCID.

  • Check how your name appears in PubMed, Scopus, Web of Science, Google Scholar, and institutional repositories.

  • Use accents and full names where supported.

  • Avoid inconsistent initials across papers.

  • Confirm metadata at proof stage.

Nature Portfolio lists author names in Roman alphabet characters as standard, while supporting some non-Roman scripts in parentheses in online HTML versions. (Nature)

A name is not just a label. It is the thread by which your work is stitched into the literature.


17. Consortium and group authorship

Large collaborations sometimes publish under a group name:

The XYZ Consortium

This is common in genomics, high-energy physics, clinical trials, epidemiology, and large observational networks. Consortium authorship helps represent large-scale work where hundreds or thousands of people contributed.

Nature Portfolio allows a collective of authors to be listed as a consortium and says all authors within a consortium must be listed at the end of the paper; members who did not directly contribute may be placed in supplementary information if necessary. (Nature)

NLM/MEDLINE handles group authors and collaborators carefully. It enters group names as they appear in the article, and when a consortium or study group appears in the byline, individual names published in the article text may be entered as collaborator names. (National Library of Medicine) NLM also states that PubMed displays authors in the order they appear in the published byline, including personal and corporate authors. (National Library of Medicine)

This matters because being a named collaborator may or may not appear the same way as being a byline author in databases, CVs, institutional metrics, and promotion dossiers. NLM notes that collaborators had a role in the research but were not necessarily authors. (National Library of Medicine)

Practical rule:

In consortium papers, clarify who is a byline author, who is a consortium member, who is a collaborator, and how the names will be indexed.

Large-team science needs large-team clarity.


18. Local authorship and research equity

Authorship is also an equity issue.

ICMJE warns editors to be aware of the exclusion of local researchers from low- and middle-income countries when data come from those countries, and notes that including local authors adds fairness, context, and implications to the research. (ICMJE) Nature Portfolio similarly encourages collaboration with colleagues where research is conducted and expects their inclusion as co-authors when they fulfill authorship criteria. (Nature)

This matters in field biology, anthropology, public health, genomics, clinical research, biodiversity, traditional knowledge, and global health. Researchers who enable study design, recruitment, interpretation, sample access, ethics, local logistics, language, cultural context, and implementation should not disappear into acknowledgements while distant institutions collect the byline harvest.

A fair paper asks:

  • Were local researchers involved in study design?

  • Did they help interpret local relevance?

  • Are they included as authors when criteria are met?

  • Are local institutions properly affiliated?

  • Are local literatures cited?

  • Are data ownership and benefit sharing clear?

Authorship should not behave like scientific extraction dressed in polite fonts.


19. Changing authors after submission

Author-list changes after submission are sensitive. Journals usually require written agreement from all authors.

ICMJE says if authors request addition or removal after submission or publication, journal editors should seek an explanation and signed agreement from all listed authors and from the author being added or removed. (ICMJE) Nature Portfolio says changes in author order, addition, deletion, corresponding author, or author sequence after submission require approval by every author, and that changes are not permitted after acceptance. (Nature)

This is why the author list should be settled before submission. Changing it later can delay review, trigger ethics queries, or reveal unresolved lab politics.

A good lab practice is to maintain an authorship decision document:

DateDecisionReasonApproved by
Jan 10A and B expected co-firstEqual experimental/data contributionAll
Mar 15C added as authorDeveloped statistical modelAll
May 2D acknowledgedTechnical imaging support onlyAll

It sounds bureaucratic until you need it. Then it becomes a lifeboat.


20. How to list authors and addresses: a practical template

Here is a clean biomedical-style template:

Title

Siya Agrawal¹, Amit Shah², Ajit Ravi Dwivedi¹,³, Nitu Singh¹*

¹ Department of Translational Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India
² Department of Cardiology, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, India
³ Present address: Department of Biological Sciences, Example University, New Delhi, India

* Correspondence: neha.arya@example.edu
† These authors contributed equally: Mukti Agrawal and Bhushan Shah.
‡ These authors jointly supervised this work: Rajeev Ranjan Dwivedi and Neha Arya.

Author contributions

S.A. performed experiments, analyzed data, prepared figures, and wrote the original draft. A.S. contributed clinical interpretation and methodology. A.R.D. contributed conceptualization, supervision, interpretation, and manuscript revision. N.S. conceived and supervised the study, secured resources, and revised the manuscript. All authors approved the final manuscript and agree to be accountable for the work.

Acknowledgements

We thank X for technical assistance with SEM imaging and Y for access to Z facility.

This kind of structure gives the paper a clean spine.


21. Common mistakes in author and address listing

MistakeWhy it mattersFix
Adding department head automaticallyGift authorship riskAdd only if authorship criteria are met
Forgetting someone who analyzed dataGhost authorship riskDiscuss contributions early
Changing order after acceptanceMay be prohibitedFinalize before submission
Using “all authors contributed equally” vaguelyNot transparentUse CRediT or detailed roles
Wrong affiliationMisallocates creditUse institution where work was done
Missing present addressReaders cannot find moved authorAdd present-address note
AI listed as authorNot acceptable under major guidanceDisclose AI tool use instead
No corresponding-author emailBlocks communicationInclude active email
Multiple meanings of symbolsConfuses readerDefine *, †, ‡ clearly
Inconsistent name spellingDamages indexingUse ORCID and consistent format

22. A small authorship etiquette code for research groups

Before the project begins:

“Who is likely to be first author? Who is senior author? What contributions could change the order?”

During the project:

“Have roles changed? Has someone contributed enough to join the author list? Has someone’s contribution remained acknowledgement-level?”

Before submission:

“Does every author meet criteria? Does everyone approve the order, affiliations, contribution statement, and final manuscript?”

After publication:

“Who handles queries, data requests, corrections, and reuse questions?”

Authorship is easiest when treated as a living conversation, not a postmortem negotiation.


Final thought: the byline is a moral instrument

A scientific paper is not written by “the lab.” It is written by people. People with hands, ideas, instruments, code, reagents, patients, field sites, late nights, arguments, failures, and oddly specific coffee rituals.

The author list should tell the truth about that work.

Not a political truth. Not a flattering truth. Not a hierarchical truth. A scholarly truth.

The best byline is not the one that keeps everyone comfortable. It is the one that makes credit and responsibility visible, defensible, and fair. When done well, the author list becomes a tiny architecture of justice at the top of the page. 🧬✍️


References and further reading

  1. International Committee of Medical Journal Editors. Defining the Role of Authors and Contributors. This is essential reading for biomedical authorship criteria, corresponding author duties, non-author contributors, and AI authorship guidance. (ICMJE)

  2. COPE. Authorship and AI tools. A key ethics position explaining why AI tools cannot be authors and why humans remain responsible for manuscript content. (Publication Ethics)

  3. CRediT. Contributor Role Taxonomy. Official resource for the 14-role taxonomy used to describe author contributions. (CRediT)

  4. Nature Portfolio. Authorship policy. Useful for corresponding author responsibilities, affiliations, consortium authorship, author contribution statements, equal contribution, joint supervision, ORCID, and global research inclusion. (Nature)

  5. Council of Science Editors. Authorship and Authorship Responsibilities. Helpful for understanding guest, gift, and honorary authorship. (councilscienceeditors.org)

  6. Waltman L. An empirical analysis of the use of alphabetical authorship in scientific publishing. Important bibliometric study on alphabetical author order across fields. (ScienceDirect)

  7. Donner P. Alphabetical author order and co-author contributions in mathematics. Useful recent analysis of mathematics as a field where alphabetical authorship remains common. (Springer)

  8. American Economic Association. What’s in a name? A clear discussion of alphabetical author order in economics and its consequences. (American Economic Association)

  9. National Library of Medicine. Authorship in MEDLINE. Useful for understanding group authors, collaborators, consortium names, and PubMed/MEDLINE indexing. (National Library of Medicine)

  10. ORCID. Open Researcher and Contributor ID. Official resource for persistent researcher identifiers and author-name disambiguation. (ORCID)

Broader Importance: Defense, Domestication, Disease, and Genome Innovation

 “potential mechanism for retrotransposon domestication”

Source: Carmi, Church, and Levanon

Why should we care about ancient APOBEC editing in repeats? Because it connects genome defense to genome innovation. APOBEC activity can disable retroelements, but in doing so it can also generate new sequence diversity. A hyperedited repeat is damaged as a mobile element, yet it may become useful raw material for the host genome.

Retroelements already contribute regulatory sequences, promoters, enhancers, splice sites, polyadenylation signals, noncoding RNAs, and sometimes protein-coding innovations. APOBEC editing adds a burst-mutagenesis mechanism. Instead of waiting for individual substitutions to accumulate slowly, a single retrotransposition event can create a heavily modified copy with a unique sequence profile.

Knisbacher and Levanon reported enrichment of edited elements in active genomic regions such as genes, exons, promoters, and transcription start sites. One interpretation is relaxed harm: edited elements are less mobile and therefore less dangerous, making them more tolerable near functional regions. Another interpretation is opportunity: some edited elements may acquire useful regulatory or exon-like features and be retained by selection.

These interpretations are not mutually exclusive. Most edited elements are probably broken debris. A few may become useful. Evolution is not tidy engineering; it is a salvage yard with surprisingly good inventory management.

The technical challenge is distinguishing retention from exaptation. An edited element overlapping a gene does not prove function. A rigorous exaptation analysis would ask: is the edited sequence transcribed? Is it bound by transcription factors? Does it carry active chromatin marks? Is it conserved across species after insertion? Does deleting or perturbing it alter gene expression? Are the APOBEC-induced bases necessary for the regulatory activity?

APOBEC editing may also complicate repeat-age estimates. Many repeat-age methods use divergence from consensus. But if a young element receives many APOBEC-induced mutations in one generation, it can appear older than it is. Knisbacher and Levanon explicitly note that DNA editing should be considered when assessing retrotransposon age from divergence. This matters for any study using repeat divergence landscapes to infer historical waves of retrotransposition.

The disease connection adds another layer. APOBEC enzymes are protective in antiviral contexts but mutagenic when misregulated. In cancer genomics, APOBEC mutational signatures are major sources of somatic mutation in many tumor types. In autoimmunity, sensing of retroelement-derived nucleic acids is implicated in inflammatory disease. The same biological family links ancient genome defense, current viral restriction, somatic mutation, and disease.

Repeat editing can also affect genome annotation. A heavily edited ERV may be misclassified because its sequence has drifted far from family consensus. ORFs may be disrupted by stop codons, especially if TGG tryptophan codons are converted through G-to-A changes. Regulatory motifs may be created or destroyed. A repeat annotation that ignores editing may split one biological family into artificial subfamilies or misestimate its activity period.

There is also an evolutionary systems point. APOBEC editing is not merely destructive. It changes the substrate on which selection acts. By disabling mobility, it can reduce immediate harm. By increasing sequence novelty, it can increase the chance of rare beneficial co-option. By leaving detectable motifs, it gives modern researchers a way to reconstruct ancient conflicts.

The broader importance, then, is not only that APOBECs fought retroelements. It is that the battle changed the genome’s creative palette. Some scars stayed scars. Some became switches, exons, promoters, or fossils with useful stories.

Key technical takeaway: APOBEC editing can both restrict retroelements and accelerate sequence diversification. It matters for repeat dating, genome annotation, exaptation studies, cancer mutational signatures, and host-defense evolution.

Monday, July 6, 2026

How to Prepare the Title: The Smallest Doorway Into Your Scientific Paper

A scientific title is tiny real estate with terrifying rent. It must satisfy editors, reviewers, indexing systems, search engines, specialists, non-specialists, and the sleep-deprived reader scrolling through PubMed at 1:17 a.m. 🧪

A title is not just a label. It is the paper’s first promise.

It tells the reader:

“This is what the paper is about. This is the system. This is the scale. This is why you may want to enter.”

A good title is accurate before it is attractive. It should not advertise a palace if the paper contains a well-built hut. It should not hide a major discovery behind vague fog. And it should not try to compress the entire manuscript into one breathless sentence.


1. What should a scientific title do?

A scientific title has four jobs:

  1. Identify the subject.

  2. Signal the study type or approach when useful.

  3. Help databases and readers retrieve the paper.

  4. Attract the correct audience without exaggeration.

Weak title:

Plant stress

Better:

Drought-responsive gene expression in Arabidopsis thaliana

More specific:

Drought-responsive transcriptional changes in root tissues of Arabidopsis thaliana

The best title depends on the work. A methods paper, genome paper, clinical trial, ecological survey, and mathematical proof do not need the same title style. The title is a tailored coat, not a universal lab apron.


2. How long should a title be?

There is no sacred number, but there are practical limits.

Nature requires titles to fit within two print lines, about 75 characters including spaces, and advises avoiding technical terms, abbreviations, and active verbs. (Nature) PLOS ONE allows a full title up to 250 characters and asks that it be specific, descriptive, concise, and understandable to readers outside the field. (PLOS) PLOS Genetics allows a full title up to 200 characters and a short title up to 70 characters. (PLOS)

A useful working range for many research articles is:

10 to 16 words, or roughly 80 to 140 characters.

This is not a law. It is a drafting compass.

Too short:

Wheat immunity

Too vague. Which wheat? Which immunity? Which method?

Too long:

Transcriptomic, metabolomic, physiological, and statistical evaluation of drought-responsive defense-associated pathways in multiple wheat cultivars under controlled greenhouse stress conditions

This title has brought luggage for a three-month expedition.

Balanced:

Drought stress reshapes immune-related transcription in bread wheat cultivars

Clear. Searchable. Specific enough. Still breathable.


3. Descriptive titles, declarative titles, and question titles

Scientific titles usually belong to three broad families.

Descriptive titles

They describe the subject without stating the main conclusion.

Gut microbiome diversity in urban and rural schoolchildren

This is safe and common. It works especially well for exploratory, observational, preliminary, or resource papers.

Declarative titles

They state the main finding.

Urbanization reduces gut microbiome diversity in schoolchildren

This is stronger and more memorable, but only use it when the evidence directly supports the claim.

Question titles

They ask a question.

Does urbanization reduce gut microbiome diversity in schoolchildren?

Question titles can work for reviews, commentaries, perspectives, or genuinely exploratory pieces. Bibliometric work shows that question titles increased over time in some fields, but their use varies strongly by discipline. Milojević found that title form and title length changed across a half-century of literature, with discipline being a major determinant of title style. (Frontiers)

For original research, a question title is often weaker than a precise descriptive title unless the paper clearly answers the question.


4. Should the title be a sentence, phrase, or two phrases?

Most scientific titles work best as phrases rather than full sentences.

Phrase:

Genome-wide association analysis of seed size in chickpea

Declarative sentence-like title:

A major locus controls seed size in chickpea

Both can work. The sentence-like version is stronger, but only if the central result is robust.

Two-phrase title using a colon:

Seed size in chickpea: A genome-wide association analysis

This works when the first phrase gives the topic and the second phrase clarifies the method or study type.

A title should usually not be a long grammatical sentence. Scientific titles are not railway announcements. They do not need to carry every clause to the final station.


5. How specific should a title be?

A title should be specific enough that the right reader can find the paper, but not so specific that it becomes a methods inventory.

Good specificity:

CRISPR-Cas9 editing of OsSWEET14 reduces bacterial blight susceptibility in rice

Too broad:

Gene editing improves rice

Too crowded:

CRISPR-Cas9-mediated targeted editing, screening, sequencing, phenotyping, and disease-resistance evaluation of OsSWEET14 mutants in rice plants under greenhouse conditions

The title should name the central object, the main action or finding, and the system. It should not list every assay, instrument, and subplot.


6. Abbreviations in titles: mostly avoid them

Abbreviations save space, but they can reduce clarity and searchability. Nature asks authors to avoid abbreviations in titles. (Nature) PLOS ONE also advises avoiding abbreviations where possible. (Learn INASP)

Usually acceptable:

DNA
RNA
HIV
COVID-19
MRI
CRISPR

Risky or too narrow:

TFBS
WGCNA
QTLseq
RBSDV
AMF

Better to spell out less universal abbreviations unless the title becomes unbearable.

Instead of:

WGCNA identifies TF modules in AMF-colonized roots

Write:

Co-expression analysis identifies transcription factor modules in mycorrhizal roots

The second title lets more readers enter the room.


7. Species names in titles

Use species names when the organism is central to the paper. PLOS Genetics asks that species names be italicized and that genus and species be written in full in the manuscript title and at first mention. (PLOS)

Good:

Chromosome-level genome assembly of Drosophila suzukii

Good with common name and scientific name:

Genome assembly of the spotted wing drosophila, Drosophila suzukii

If the organism is only a model and the broader biological point matters more, the common name may be enough for some journals:

Zebrafish larvae reveal conserved pathways of neural regeneration

Follow the journal’s style. Species names are not decorative Latin glitter. They are precision instruments.


8. Gene names and protein names in titles

Gene names should follow accepted nomenclature. The HUGO Gene Nomenclature Committee provides approved human gene symbols and names. (GeneNames) For many journals, gene symbols are italicized when referring to genes, while proteins are generally not italicized.

Gene title:

Loss of BRCA1 alters DNA repair pathway choice in epithelial cells

Protein title:

BRCA1 regulates DNA repair pathway choice in epithelial cells

If several genes are involved, avoid turning the title into alphabet soup.

Too crowded:

TP53, BAX, BCL2, CASP3, VEGFA, and HIF1A expression after treatment X

Better:

Treatment X shifts apoptotic and angiogenic gene expression in endothelial cells

Use gene names when they are the main discovery, target, or searchable anchor.


9. Should years appear in titles?

Use years when the time period is scientifically meaningful.

Good:

Global dengue burden from 1990 to 2023

Good:

Antibiotic resistance trends in bloodstream infections, 2010 to 2024

Unnecessary:

Development of a new microscopy workflow in 2026

Years are especially useful for epidemiology, surveillance, systematic reviews, meta-analyses, outbreak reports, policy studies, climate datasets, and historical analyses.

For reviews:

Marine microplastics and fish health, 2015 to 2025: A systematic review

For most laboratory studies, skip the year unless it defines the dataset or study design.


10. The colon: useful, but do not overfeed it

The colon is the classic tool for a two-part title:

Broad concept: specific study

Example:

Soil memory: Microbial legacy effects after repeated drought

Example:

Mapping insect decline: Long-term monitoring across agricultural landscapes

This works when the first phrase is meaningful and the second phrase adds precision.

Weak:

A new approach: Analysis of sleep quality in students

Better:

Sleep quality in university students: A cross-sectional survey

Buter and van Raan found that non-alphanumeric characters are very common in scientific titles, especially hyphens, colons, commas, and parentheses, although their association with citation impact varies by discipline. (ScienceDirect)

Use a colon when it clarifies structure. Do not use it because the title feels lonely.


11. Commas, hyphens, parentheses, slashes, and question marks

Commas

Useful for short, controlled descriptions:

A low-cost, portable sensor for arsenic detection in groundwater

Too many commas become a procession of adjectives:

A rapid, robust, scalable, portable, affordable, sensitive, accurate sensor

That title is trying to win a grant panel by adjectives alone.

Hyphens

Useful for compound modifiers:

Field-based detection
Long-term monitoring
Single-cell analysis

Avoid hyphen thickets:

Multi-layered-high-throughput-field-deployable-sequencing-based-tool

No reader deserves that hedgehog.

Parentheses

Use sparingly for standard acronyms, trial names, or model systems.

Solar water disinfection to reduce childhood diarrhoea in rural Bolivia: A cluster-randomized trial

PLOS gives examples of titles that include a study design in the subtitle, especially for clinical trials and systematic reviews. (PLOS)

Slash

Use only for standard pathways or terms:

Nrf2/HO-1 signaling
Host/pathogen interactions

Avoid slash chains:

Plant/microbe/soil/climate interactions

Question mark

Use mainly for reviews, perspectives, and debate papers.

Are urban trees cooling cities equitably?

For original research, a statement is often stronger:

Urban tree cover reduces heat exposure unevenly across neighborhoods

Only use that if the data show it.

Em dash

For formal scientific article titles, avoid it unless the journal style clearly allows it. A colon, comma, or parenthesis usually does the job more cleanly.


12. Flashy titles: charm versus cheese

Flashy titles can be memorable, especially in reviews, essays, ecology, evolution, and perspectives. But they can also sound unserious or vague.

Too flashy:

The secret life of sleepy bacteria

Better:

Dormancy and stress tolerance in bacterial persister cells

Balanced:

The sleep of microbes: Dormancy and stress tolerance in bacterial persister cells

Creativity can help when clarity survives. A 2023 study in ecology and evolution examined humor and other title features, showing that creative title features can be studied empirically rather than dismissed by instinct. (Frontiers) Still, the safest rule is:

Be clever only after being clear.

Title sparkle should be spice, not the whole curry.


13. “Decoding,” “illuminating,” “deciphering,” and other title lanterns

Many modern titles start with words like:

  • Decoding

  • Illuminating

  • Deciphering

  • Unraveling

  • Revealing

  • Mapping

  • Profiling

  • Engineering

  • Harnessing

  • Dissecting

These can work, but they are often overused.

Good:

Decoding enhancer evolution in primate genomes

Better, if more precise:

Enhancer turnover shapes primate-specific gene regulation

Weak:

Illuminating the role of bacteria in health

Too vague. Which bacteria? Which health? Which method?

Better:

Gut bacterial diversity predicts inflammatory markers in older adults

If the title begins with “decoding” or “illuminating,” ask:

Did the study truly decode something, or did it measure, compare, map, or test something?

Often the plain verb is stronger.


14. “Novel,” “first,” and “new”: handle with tongs

Words such as “novel,” “first,” and “new” are tempting, but they can weaken a title.

Weak:

A novel machine learning approach for crop disease detection

Better:

A transformer-based model for early detection of wheat rust from leaf images

If it is truly novel, the specificity will show it. “Novel” is often an empty sparkle-word. It says, “trust me,” when the title should say, “inspect this.”

Use “first” only when the literature has been checked carefully and the claim is narrow.

Risky:

First report of fungal diversity in India

Safer:

Culture-independent profiling of fungal diversity in dry deciduous forests of central India

The second is precise and avoids an argument with a reviewer who has read everything since 1978.


15. Descriptive versus result-describing titles

Descriptive:

Single-cell transcriptomics of zebrafish retinal regeneration

Result-describing:

Müller glia generate neuronal progenitors during zebrafish retinal regeneration

Result-describing titles are powerful when the result is clear. They are risky when the evidence is preliminary.

Evidence on title length and impact is mixed. Letchford and colleagues found that journals publishing papers with shorter titles tended to receive more citations per paper. (Royal Society Publishing) Habibzadeh and Yadollahie found that shorter titles did not necessarily receive more citations and reported different patterns. (PMC)

The practical lesson is not “always be short” or “always be long.” It is:

Use the shortest title that still carries the necessary scientific identity.


16. How title trends have changed over time

Scientific titles have become more searchable, more informative, and more field-specific. Earlier titles were often shorter and sometimes cryptic, partly because papers were encountered through printed journals and specialist reading habits. Digital discovery changed the game. A title now has to work in databases, alerts, search engines, reference managers, and social media snippets.

Milojević’s analysis across five fields found that title length, subtitles, question titles, and indicative titles changed over a 50-year period, with strong disciplinary differences. (Frontiers) Hyland and Zou also emphasize that article titles now serve a major role in online discoverability because readers often search for individual articles rather than browse entire journal issues. (Frontiers)

Broadly, titles have moved from:

compact labels for specialist readers

towards:

searchable summaries for mixed human and machine audiences

This is why keywords matter more than before. The title is now metadata with a pulse.


17. Differences across fields

Different disciplines have different title cultures.

Mathematics

Often compact and abstract:

On the zeros of L-functions

Question titles and subtitles are less common in some mathematical fields, consistent with Milojević’s finding that discipline strongly shapes title practices. (Frontiers)

Ecology and evolution

More tolerant of metaphor, humor, and conceptual titles:

Life in the canopy: Ant communities across forest fragments

Molecular biology and genetics

Often include genes, pathways, model organisms, or methods:

FOXP2 variation affects vocal learning pathways in songbirds

Clinical medicine

Often includes population, intervention, outcome, and study design:

Treatment X for severe asthma in adults: A randomized controlled trial

Computer science and AI

Often emphasizes method and task:

Self-supervised transformers for low-resource speech recognition

Chemistry and materials science

Often names the material and function:

Porous carbon nitride catalysts for visible-light hydrogen evolution

There is no single perfect title style. A brilliant ecology title may look too playful in a surgical journal. A precise molecular title may look overstuffed in a mathematics journal.


18. Differences across journals

Journals have their own title weather.

Nature asks for very short titles and discourages technical terms, abbreviations, and active verbs. (Nature) PLOS ONE allows longer titles and asks authors to make them specific, descriptive, concise, and understandable beyond the immediate subject field. (PLOS) PLOS Genetics also has journal-specific rules for title length and species names. (PLOS)

So the same study may need different title versions.

For a broad journal:

Ancient DNA reveals migration across the Himalayas

For a specialist journal:

Genome-wide ancient DNA analysis reveals Bronze Age migration across Himalayan corridors

For a methods-focused journal:

A low-coverage ancient DNA pipeline for population inference in degraded samples

Same work. Different doorway.


19. Differences across countries and writing cultures

Country-level trends in article titles are harder to generalize than field-level or journal-level trends. Many studies of title style focus on disciplines, journals, and citation patterns rather than national writing cultures. The safest claim is that title style is shaped by target journal norms, field conventions, English-language publishing practices, and indexing expectations more than by a single national style.

For authors writing in English as an additional language, the strongest strategy is clarity rather than ornament.

Over-grand:

Illuminating the magnificent hidden dimensions of educational transformation

Clear:

Teacher feedback practices in undergraduate biology classrooms

International scientific English is not created by adding thunder. It is created by removing fog.


20. Should the title include the method?

Include the method if it is central to the contribution or if readers search by it.

Good:

Single-cell RNA sequencing reveals immune cell diversity in the human placenta

Good:

A Bayesian model for estimating crop yield from satellite imagery

Do not include every method:

PCR, qPCR, ELISA, microscopy, and flow cytometry analysis of immune responses

Better:

Cellular and cytokine responses after influenza vaccination in older adults

Methods belong in the title only when they are the story, not when they are the toolbox.


21. Should the title include the conclusion?

Only when the evidence is strong.

Good:

Urban green space reduces daytime heat exposure in low-income neighborhoods

Use this only if the data directly support that conclusion.

Safer descriptive version:

Urban green space and daytime heat exposure in low-income neighborhoods

A declarative title makes a claim before the abstract begins. Make sure the paper can carry that weight.


22. Series titles: use only when the series is real

Series titles can work for planned multi-part studies, monographs, large consortia, or themed issues.

Example:

Evolution of island birds I: Genome assembly and demographic history

Evolution of island birds II: Comparative analysis of immune gene loss

But do not invent a series for drama.

Bad:

The great genome adventure I: Dawn of the dataset

Charming, perhaps. Publishable, perhaps not.


23. Practical title formulas

Original research

[Main finding] in [system]

Example:

Salt stress alters root microbiome assembly in rice

Descriptive observational study

[Variable] in [population/system]

Example:

Sleep duration and academic performance in first-year medical students

Methods paper

[Method] for [task]

Example:

A graph-based method for detecting structural variants in long-read genomes

Genome paper

[Genome assembly/resource] of [species] reveals [insight]

Example:

Chromosome-level genome assembly of Cicer arietinum reveals drought-adaptation loci

Systematic review

[Topic]: A systematic review and meta-analysis

Example:

Urban air pollution and childhood asthma: A systematic review and meta-analysis

Perspective or commentary

[Conceptual hook]: [specific issue]

Example:

Beyond p-values: Designing reproducible experiments in small laboratories


24. A title revision checklist

Before finalizing, ask:

QuestionWhy it matters
Does the title match what was directly studied?Prevents overclaiming
Is the main keyword present?Improves retrieval
Is the organism, disease, or system included when central?Improves precision
Are abbreviations minimized?Improves readability
Is the study design included when required?Helps clinical and review readers
Are species and gene names formatted correctly?Prevents nomenclature errors
Is the title short enough for the target journal?Avoids desk-formatting trouble
Is it too vague?Avoids invisibility
Is it too crowded?Avoids reader fatigue
Does it sound like advertising?Protects credibility

25. Common title surgeries

Remove empty novelty words

Before:

A novel approach for detecting crop disease

After:

Deep learning detection of wheat rust from smartphone leaf images

Replace vague drama

Before:

Deciphering the mysteries of soil health

After:

Soil microbial diversity predicts nitrogen retention in restored grasslands

Add study design

Before:

Air pollution and childhood asthma

After:

Air pollution and childhood asthma: A systematic review and meta-analysis

Remove method overload

Before:

PCR, sequencing, microscopy, and ELISA analysis of bacterial infection

After:

Host immune responses during bacterial infection in zebrafish larvae

Make the claim honest

Before:

A probiotic formulation cures inflammatory bowel disease

After:

A probiotic formulation reduces inflammatory markers in a mouse colitis model

That one word, “mouse,” saves the title from becoming a tiny billboard of doom.


Final thought: the title is a promise

A title should be specific but not swollen, attractive but not theatrical, searchable but not stuffed, and confident but not reckless.

It should not claim what the paper did not test. It should not hide what the paper truly offers. It should invite the right reader, not trap the wrong one.

A good scientific title is the smallest honest abstract of the work. It opens the door, lights the hallway, and does not pretend the house has rooms that were never built. 🔬✨


References and further reading

  1. Hyland K, Zou H. Titles in research articles. Useful for title structure, disciplinary differences, and online discoverability. (Frontiers)

  2. Milojević S. The Length and Semantic Structure of Article Titles: Evolving Disciplinary Practices and Correlations with Impact. Useful for how titles changed across fields over 50 years. (Frontiers)

  3. Buter RK, van Raan AFJ. Non-alphanumeric characters in titles of scientific publications: An analysis of their occurrence and correlation with citation impact. Useful for punctuation such as colons, hyphens, commas, and parentheses. (ScienceDirect)

  4. PLOS ONE. Submission Guidelines: Title. Useful for title length, short title, abbreviations, and study-design subtitles. (PLOS)

  5. PLOS Genetics. Submission Guidelines: Title and nomenclature. Useful for species names, title length, and biological nomenclature. (PLOS)

  6. Nature. Initial submission guidelines. Useful for very short title expectations in broad high-impact journals. (Nature)

  7. HGNC. HUGO Gene Nomenclature Committee resources. Essential for approved human gene symbols and nomenclature. (GeneNames)

  8. Letchford A, Moat HS, Preis T. The advantage of short paper titles. Useful for the debate around title length and citations. (Royal Society Publishing)

  9. Habibzadeh F, Yadollahie M. Are shorter article titles more attractive for citations? Useful because it complicates the idea that shorter titles always perform better. (PMC)

What Is a Scientific Paper? A Field Guide to the Strange Little Creature Called “the Literature”

A scientific paper is not just a document. It is a claim-making machine.

At its best, it says:

“Here is a question. Here is what we did. Here is what we found. Here is how confident you should be. Here is what this does not prove. Here is enough information for others to inspect, repeat, challenge, or build on it.”

That is the soul of the scientific paper. Not the PDF. Not the DOI. Not the fancy journal logo perched like a jeweled beetle on the first page. A scientific paper is a structured contribution to the shared memory of science.

But the moment we say “paper,” the jungle thickens. There are original articles, reviews, systematic reviews, meta-analyses, brief communications, letters, case reports, conference papers, preprints, protocols, data papers, registered reports, editorials, corrections, and database records. Some are peer-reviewed. Some are not. Some count as prior publication. Some usually do not. Some are indexed. Some are merely discoverable. Some are real papers wearing informal clothes. Some are just abstracts with ambition.

Let us sort the cabinet 🧪📚.


1. The scientific paper as a public claim

A scientific paper is a formal scholarly work that communicates research, analysis, interpretation, or commentary to a community. In modern journal publishing, the most important version is usually the Version of Record, the fixed, citable version formally published by a journal or publisher. DOI infrastructure such as Crossref helps make research objects persistent and discoverable by registering metadata and persistent identifiers, but a DOI itself does not magically certify quality or peer review. It is a signpost, not a halo. (www.crossref.org)

A good scientific paper does three jobs at once:

JobWhat it gives the reader
CommunicationWhat was done and found
CertificationWhether the work passed some editorial or peer-review process
ArchivingA durable, citable record for future scholarship

The third job is often overlooked. A paper is not only written for today’s reader. It is written for a future graduate student, a systematic reviewer, a patent examiner, a meta-analyst, a policy writer, a skeptical rival, and some tired scientist in 2037 trying to understand why Figure 2B mattered.


2. Primary literature: where new evidence first enters the room

Primary literature reports original research or first-hand scientific evidence. In the sciences, primary literature usually includes original research articles where authors describe their own experiments, observations, fieldwork, clinical data, simulations, datasets, or analyses. Library and information-science guides commonly define primary scientific literature as work that presents original research or new scientific discoveries. (library.onu.edu)

Examples of primary literature include:

TypeWhat it contains
Original research articleNew experimental, observational, clinical, computational, or theoretical findings
Clinical trial reportResults of a study where participants are assigned interventions according to a protocol
Case reportDetailed report of an unusual clinical case or small case series
Brief communicationShort report of an important but compact finding
Methods paperNew experimental, analytical, computational, or statistical method
Data paperDescription of a dataset, usually with metadata and reuse guidance
Registered reportStudy accepted in principle before results are known, usually after peer review of rationale and methods

The National Library of Medicine’s publication types include categories such as clinical trial, review, case reports, systematic review, randomized controlled trial, and others, showing how databases classify scholarly works by their content or style. (National Library of Medicine)

A primary paper is where the evidence first walks onstage.


3. Secondary and tertiary literature: the evidence gets digested

If primary literature is the raw harvest, secondary literature is the kitchen.

Secondary literature analyzes, interprets, evaluates, or synthesizes primary studies. Review articles are the classic example. An NCBI Bookshelf chapter describes review articles as journal-length papers whose purpose is to synthesize literature in a field, without collecting or analyzing new primary data. (NCBI)

Examples:

TypePurpose
Narrative reviewBroad expert synthesis, often less protocolized
Systematic reviewStructured search, selection, appraisal, and synthesis of evidence
Meta-analysisStatistical pooling of results from multiple studies
Scoping reviewMaps the range and nature of evidence in a field
Perspective or opinionInterpretive argument, often expert-led
EditorialJournal or invited commentary on a paper, issue, or field

Tertiary literature includes textbooks, encyclopedias, manuals, and reference works. These usually summarize established knowledge rather than introduce new evidence.

A useful shortcut:

Primary literature says: “We found this.”
Secondary literature says: “Here is what many studies together suggest.”
Tertiary literature says: “Here is what the field currently teaches.”


4. Not every scientific paper has the same job

Scientific papers are like tools in a surgical tray. Mistaking one for another leads to scholarly finger injuries.

Original research article

This is the standard primary research paper. It usually contains Introduction, Methods, Results, and Discussion. The ICMJE notes that original research articles are often organized in this structure because it reflects the process of scientific discovery. (ICMJE)

Short communication or letter

This reports a compact but important observation. It may have fewer figures, shorter methods, and limited discussion. It is still primary literature if it reports new data.

Case report

A case report describes one or a small number of patients. It is valuable for rare presentations, unexpected adverse effects, new syndromes, or clinical teaching. It usually sits lower in evidence hierarchies than randomized trials or systematic reviews, but it can be the first flare in the fog.

Methods paper

A methods paper introduces or validates a technique. It can be primary literature if it presents original performance data, benchmarking, validation, or implementation.

Protocol paper

A protocol paper describes what will be done before results are available. It is not a results paper. Its value lies in transparency, preventing outcome-switching, and helping others inspect the planned design.

Registered report

A registered report flips the usual publishing suspense. The rationale and methods are peer-reviewed before data collection or before results are known. If the study is conducted as approved, the journal commits to publication regardless of whether results are positive, negative, or inconvenient.

Data paper

A data paper describes a dataset: how it was generated, curated, validated, formatted, and how it can be reused. The dataset itself may live in a repository, but the data paper is a citable scholarly article about the dataset.

Review article

A review article synthesizes what is already known. A systematic review or meta-analysis can be extremely important, but it is usually secondary literature because it analyzes prior studies rather than reporting new experimental data.

Editorial, commentary, correspondence

These are scholarly conversation pieces. They may critique, contextualize, praise, question, or extend published work. They are part of the literature, but they are usually not primary evidence unless they contain new data.

Correction, expression of concern, retraction

These are maintenance tools for the scholarly record. They are not glamorous, but they are essential. Science without correction would become a museum of polished mistakes.


5. Abstracting and indexing services: the librarians of the literature

Publishing and indexing are not the same thing.

A journal publishes a paper. An indexing or abstracting service makes that paper findable, classifiable, searchable, and sometimes measurable.

Important examples:

ServiceWhat it does
PubMedSearch platform for biomedical citations from MEDLINE, life science journals, and online books
MEDLINEMajor curated component of PubMed, with selected journals and MeSH indexing
PubMed CentralFree full-text archive of biomedical and life-science journal literature
ScopusAbstract and citation database curated by independent subject experts
Web of Science Core CollectionCurated multidisciplinary citation index
DOAJIndex of open-access journals committed to quality open availability
CrossrefDOI and metadata infrastructure linking scholarly records

PubMed comprises more than 40 million citations from MEDLINE, life science journals, and online books, while PubMed Central is a free full-text archive maintained by the U.S. National Library of Medicine. (PubMed) MEDLINE is the largest component of PubMed and includes journals selected for MEDLINE, with MeSH indexing and curated metadata. (PubMed)

This distinction matters. A paper having a PMID means it has a PubMed record. It does not automatically mean the journal is indexed in MEDLINE. The NLM explicitly decides whether a journal’s scientific and editorial quality merit MEDLINE inclusion. (National Library of Medicine)

Scopus describes itself as a source-neutral abstract and citation database curated by an independent Content Selection Advisory Board, while Clarivate describes Web of Science Core Collection as a curated multidisciplinary citation database built through editorial selection. (www.elsevier.com) DOAJ is an index of open-access journals that aims to ensure quality content is openly available. (Directory of Open Access Journals)

A tiny but important warning:

Indexed does not mean perfect.
Not indexed does not always mean bad.
But indexing does affect visibility, credibility, evaluation, and discoverability.

A paper can exist without being indexed. But without indexing, it may drift like a message in a bottle across a very large ocean.


6. Preprints: papers before the ceremonial gate

A preprint is an author’s version of a research manuscript made publicly available before formal peer review by a journal. Springer Nature defines preprints as author versions of research manuscripts deposited on public servers before formal peer review. (Springer Nature Support)

Preprints are important because they:

  • make work visible quickly,

  • establish a timestamp of priority,

  • invite community feedback,

  • allow early sharing during fast-moving research,

  • improve access for readers without subscriptions.

But a preprint is not the same as a peer-reviewed journal article. It is a manuscript in public, not a final certified record. It may later change substantially, be rejected, be published elsewhere, or never be formally published.

Many major publishers do not treat preprints as prior publication. Nature Portfolio says posting preprints is not considered prior publication and will not jeopardize consideration at its journals. (Nature) Springer Nature similarly states that posting preprints is not considered prior publication for Springer Nature journals. (Springer Nature Support) ACS also allows authors to deposit initial drafts in preprint services such as ChemRxiv, bioRxiv, and arXiv. (American Chemical Society Publications)

But the rules are not universal. COPE emphasizes that what counts as prior publication varies between journals and disciplines, and that journals should communicate their policies clearly. (Publication Ethics)

So the practical rule is:

A preprint is usually not prior journal publication, but always check the target journal’s policy.

Preprints are the scholarly equivalent of opening the lab window before the official lecture begins. Useful, democratic, breezy, occasionally chaotic.


7. What counts as prior publication?

This is where the swamp bubbles.

There is no single global police officer of prior publication. The answer depends on journal policy, publisher policy, discipline, article type, extent of overlap, copyright status, peer-review status, and transparency.

The ICMJE gives influential biomedical guidance on overlapping publications. It says authors should not submit the same manuscript to more than one journal simultaneously, because this can waste peer-review effort and create conflicts between journals. (ICMJE) ICMJE also recognizes acceptable secondary publication under certain conditions and treats manuscripts based on the same database as potentially independent if they differ in analytical methods, conclusions, or both. (Research Integrity in Law)

Here is a practical map:

Material already publicUsually considered prior publication?What to do
Same full paper already published in a journalYesDo not submit as original article
Same manuscript under review elsewhereDuplicate submission, not allowedSubmit to only one journal at a time
Preprint on recognized serverUsually no, but journal-specificDisclose and cite/link it
Conference abstractOften no, if briefDisclose if relevant
Full conference proceedings paperSometimes yes, depending on overlap and fieldCheck journal policy, cite, explain extension
Thesis or dissertation in repositoryOften no, but journal-specificCheck policy, disclose if asked
Poster or oral presentationUsually noMention if required
Protocol registrationNo, usually required or encouragedProvide registry details
Dataset in public repositoryUsually no, but it is public dataCite accession/DOI and disclose
Previously published figures or textYes for that materialGet permission, cite, avoid duplicate publication
Pre-registered report or protocol paperIt is a publication, but results paper may still be validCite and distinguish results
Blog post or non-peer-reviewed essay with same analysisDepends on content and journalDisclose, avoid text recycling

For theses, COPE does not impose one universal answer. It says journals and publishers need clear guidance for authors on prior publication and theses. (Publication Ethics) For conference proceedings, Nature Portfolio policies ask authors to disclose proceedings papers, cite them, obtain permissions for reused material, and attribute appropriately. (Nature)

The hidden monster here is not merely “prior publication.” It is redundant publication, text recycling, and salami slicing.

  • Redundant publication means publishing substantially the same work more than once without proper justification.

  • Text recycling means reusing your own text without transparency or permission where needed.

  • Salami slicing means splitting one study into multiple thin papers without a valid scientific reason.

A second paper from the same dataset can be legitimate if it asks a different question, uses different analyses, and clearly cites the related work. ICMJE notes that manuscripts based on the same database may be considered independently when analytic methods or conclusions differ. (Research Integrity in Law)


8. Trial registration is not publication, but it is public accountability

Clinical trial registration is not the same as publishing a paper. It is a public record of a planned or ongoing study. ICMJE says the purpose of clinical trial registration is to prevent selective publication and selective reporting, prevent unnecessary duplication, inform patients and the public, and help ethics boards see related work. (ICMJE)

This is crucial. A trial registry entry tells the world:

“This study exists, these outcomes were planned, and the results cannot quietly vanish if inconvenient.”

A trial registry is not a paper, but for clinical research it is part of the ethical scaffolding around the paper.


9. Is depositing in a database “publishing”?

This is the excellent, thorny question.

The answer is: it depends what you mean by publishing.

In the broad sense

Yes, depositing data in a public database is a form of public dissemination. It creates a timestamped, citable, accessible research object. GenBank, for example, is the NIH genetic sequence database and an annotated collection of publicly available DNA sequences. It is part of the International Nucleotide Sequence Database Collaboration, along with DDBJ and ENA, and these organizations exchange data daily. (NCBI)

In the journal-publication sense

No, a database deposit is usually not equivalent to a peer-reviewed research article. A GenBank accession, SRA BioProject, GEO dataset, PDB structure, Dryad dataset, Zenodo DOI, or Figshare record can be cited and reused, but it is not automatically a full scientific paper unless accompanied by a formally published article or data paper.

In the prior-publication sense

Usually, depositing required data in a recognized repository is not treated as prior publication of the manuscript. In fact, many journals require or strongly encourage it. PLOS requires authors to make all data necessary to replicate findings publicly available at publication, and PLOS Biology asks authors to deposit appropriate datasets in public repositories and provide accession numbers or dataset DOIs in the manuscript. (PLOS) Springer Nature strongly encourages public availability of supporting datasets and mandates sharing of some community-endorsed data types, with persistent identifiers such as DOIs or accession numbers cited in the article. (Springer Nature)

So, a useful distinction:

ObjectIs it public?Is it peer-reviewed article publication?Can it count as prior publication?
GenBank accessionYesNoUsually no
Zenodo dataset DOIYesNoUsually no
Data paper in a journalYesYesYes, for that data description
Full conference proceedings paperYesSometimes peer-reviewedMay count, depending on journal
PreprintYesNo formal journal peer reviewUsually no, but policy-specific
Journal articleYesUsually yesYes

Database deposition is publishing in the sense of making public. It is not usually publishing in the sense of peer-reviewed article publication. The distinction is small, but it carries a cathedral on its back.


10. What about abstracting services? Are abstracts “published”?

An abstract in a conference booklet, conference supplement, or indexing database is public, but it is not the same as a full paper.

A conference abstract may establish that the work was presented. It may contain preliminary results. It may be citable. But many journals still allow later full publication if the full paper substantially expands the work, includes complete methods, full data, analysis, and discussion, and discloses the earlier abstract. Policies vary, especially when the conference output is a full peer-reviewed proceedings paper rather than a 250-word abstract.

Indexing an abstract does not create a new publication. It creates a searchable record of something already published or deposited. PubMed, Scopus, Web of Science, and DOAJ are discovery systems. They do not themselves transform weak work into strong work, nor do they convert an abstract into a full article. They help the scholarly ecosystem find, classify, and count things.

A paper can be:

  • published but not indexed,

  • indexed but not in the database you care about,

  • in PubMed but not MEDLINE,

  • in PMC full text but not necessarily MEDLINE-indexed,

  • assigned a DOI but not necessarily peer-reviewed.

These are separate badges. Do not confuse the medals on the uniform.


11. Who defines these things?

No single person. No single office. No single ancient council of owls, sadly 🦉.

Definitions are produced by overlapping authorities:

AuthorityWhat it shapes
JournalsArticle types, acceptance rules, prior-publication policy
PublishersEthical policies, preprint policy, data policy, copyright
ICMJEBiomedical manuscript and publication recommendations
COPEPublication ethics guidance for editors and publishers
NLM/MEDLINEIndexing and journal-selection decisions for MEDLINE
Scopus/Web of Science/DOAJDatabase inclusion and curation criteria
FundersOpen-access, data-sharing, trial-registration mandates
InstitutionsThesis, repository, authorship, misconduct policies
Disciplinary communitiesNorms around preprints, conference papers, datasets
Repositories/databasesSubmission, accession, release, metadata standards

ICMJE recommendations are influential in biomedical journals, especially around authorship, overlapping publication, trial registration, manuscript preparation, and data sharing. (ICMJE) COPE provides publication-ethics guidance and emphasizes that editors must communicate clear policies, especially on issues such as prior publication and preprints. (Publication Ethics) NLM decides whether a journal merits inclusion in MEDLINE, using scientific and editorial quality considerations and external expert advice. (National Library of Medicine)

So when someone asks, “Is this already published?” the scientific answer is often:

“According to whose policy, for what purpose, and with how much overlap?”

That may sound slippery, but it is accurate.


12. A practical decision guide for researchers

Before submitting a paper, ask these questions:

  1. Has the same full manuscript appeared elsewhere?
    If yes, it is likely prior publication.

  2. Was it posted as a preprint?
    Usually acceptable, but disclose it and check the journal.

  3. Was it part of a thesis?
    Usually manageable, but check journal policy and disclose when asked.

  4. Was it a conference abstract or full proceedings paper?
    Abstracts are often acceptable. Full proceedings papers need careful checking.

  5. Are the same data used in another paper?
    Make sure the new paper asks a distinct question, uses appropriate analysis, and cites the related work.

  6. Have data been deposited in a repository?
    Usually good and often required. Cite the accession or DOI.

  7. Was any text, figure, or table reused?
    Cite, disclose, get permission if needed, and avoid copyright trouble.

  8. Does the target journal have a specific policy?
    The journal’s policy is the door lock. Do not arrive with the wrong key.


13. Why this matters

These distinctions are not bureaucratic hair-splitting. They protect the integrity of the scientific record.

  • Primary papers introduce evidence.

  • Reviews digest evidence.

  • Preprints accelerate visibility.

  • Databases preserve reusable objects.

  • Indexes make scholarship discoverable.

  • DOI systems connect the record.

  • Trial registries reduce selective reporting.

  • Prior-publication policies prevent duplication and distortion.

The scientific literature is not a bookshelf. It is an ecosystem. Some organisms produce oxygen. Some decompose old claims. Some pollinate new ideas. Some are invasive weeds with suspiciously glossy leaves. A good researcher learns taxonomy before wandering too deep.


Final thought: a paper is not just “published.” It is positioned.

The same research can exist in many forms: a conference poster, a preprint, a thesis chapter, a dataset, a protocol, a peer-reviewed paper, a review article, a database accession, a press release, and a policy brief.

They are not interchangeable.

A scientific paper becomes trustworthy not merely because it is public, indexed, or citable. It becomes trustworthy when its claims, evidence, methods, limits, and provenance are clear enough for the community to examine.

That is the real publication event: not ink on paper, not a PDF online, but evidence entering the public arena with its armor properly labeled.


Further reading resources

  • ICMJE Recommendations: essential for biomedical authorship, manuscript preparation, overlapping publication, trial registration, and data sharing. (ICMJE)

  • COPE guidance on preprints and prior publication: useful for understanding why policies vary across journals and disciplines. (Publication Ethics)

  • PubMed, MEDLINE, and NLM resources: useful for understanding how biomedical papers are indexed and how MEDLINE selection works. (PubMed)

  • Nature Portfolio preprint and conference-proceedings policies: helpful examples of how major journals handle preprints and prior conference outputs. (Nature)

  • Springer Nature research data policy: useful for understanding data availability statements, public repositories, and mandated data deposition. (Springer Nature)

  • PLOS data availability policy: a clear example of strong data-sharing expectations and repository use. (PLOS)

  • GenBank overview: important for researchers working with DNA sequence data and accession-based citation. (NCBI)

  • Scopus, Web of Science, DOAJ, and Crossref documentation: useful for understanding indexing, citation databases, open-access journal discovery, and DOI metadata infrastructure. (www.elsevier.com)